10-Q: ATI Physical Therapy Reports Q3 2024 Results Amidst Liquidity Concerns

ATI Physical Therapy's Q3 2024 results show increased revenue driven by higher patient volumes, but the company continues to face liquidity challenges and substantial doubt about its ability to continue as a going concern.

Summary

• ATI Physical Therapy reported a net loss of $32.9 million for the third quarter of 2024, compared to a net loss of $14.6 million in the same period last year.
• Net patient revenue increased to $174.7 million, up from $162.3 million in Q3 2023, driven by higher patient visit volumes.
• The company's total patient visits reached 1.59 million, an increase of 7.8% year-over-year.
• However, the company's cash position remains tight, with $23.5 million in cash and no available capacity under its revolving credit facility as of September 30, 2024.
• ATI has generated negative operating cash flows of $31.4 million and a net loss of $48.9 million for the nine months ended September 30, 2024.
• The company acknowledges substantial doubt about its ability to continue as a going concern and expects to need additional liquidity by early 2025.
• The company is exploring options such as raising additional debt or equity, asset disposals, and other strategic alternatives to improve its financial condition.
• The company's debt includes a Senior Secured Term Loan of $410 million and 2L Notes with a fair value of $108.8 million.
• The company has also issued $10.5 million of Second Lien Loans subsequent to the quarter end.

Sentiment

Score: 3

Explanation: The document presents a mixed picture with positive revenue growth offset by significant losses, liquidity concerns, and a going concern warning. The overall sentiment is negative due to the financial instability and uncertainty surrounding the company's future.

Positives

• The company experienced a 7.7% increase in net patient revenue in Q3 2024 compared to Q3 2023.
• Patient visit volumes increased by 7.8% in Q3 2024, indicating improved demand for services.
• The company's average visits per day increased by 6.1% in Q3 2024.
• The company has implemented actions to improve clinical staffing levels and reduce attrition.
• The company is actively working to improve its operating results and cash flow.

Negatives

• The company's net loss increased to $32.9 million in Q3 2024, compared to $14.6 million in Q3 2023.
• The company's cash position is tight, with only $23.5 million in cash and no available capacity under its revolving credit facility.
• The company has generated negative operating cash flows of $31.4 million for the nine months ended September 30, 2024.
• The company acknowledges substantial doubt about its ability to continue as a going concern.
• The company expects to need additional liquidity by early 2025.

Risks

• The company's liquidity position raises substantial doubt about its ability to continue as a going concern.
• The company is at risk of insufficient funding to meet its obligations as they become due.
• The company is at risk of potential non-compliance with its minimum liquidity financial covenant under its 2022 Credit Agreement.
• The company faces risks related to its ability to access additional financing or alternative options when needed.
• The company is dependent on reimbursement by governmental and third-party payors, and decreases in reimbursement rates could adversely affect financial results.
• The company faces competition for experienced physical therapists and other clinical providers, which may increase labor costs and reduce profitability.
• The company's operations are subject to extensive regulation and macroeconomic uncertainty.
• The company's ability to meet revenue and earnings expectations is uncertain.
• The company's efforts to regain and sustain compliance with the listing requirements of the NYSE are subject to risk.

Future Outlook

The company expects to need additional liquidity by early 2025 and is exploring options such as raising additional debt or equity, asset disposals, and other strategic alternatives to improve its business, results of operations and financial condition. There is no assurance that the company will be successful in accessing such alternative options or financing if or when needed.

Management Comments

• Management is focused on increasing clinical staffing levels, improving clinician productivity, increasing patient visit volumes and referrals, and controlling costs and capital expenditures.
• Management acknowledges substantial doubt about the company's ability to continue as a going concern.

Industry Context

The outpatient physical therapy industry is experiencing growth, driven by an aging population and a focus on value-based care. However, the industry is also facing challenges such as a tight labor market for physical therapists and changes in reimbursement rates. ATI's results reflect these broader industry trends, with increased patient volumes but also challenges related to staffing and profitability.

Comparison to Industry Standards

• ATI's revenue growth of 7.7% in Q3 2024 is comparable to some industry peers, but its profitability and liquidity challenges are more pronounced.
• Companies like Select Medical and U.S. Physical Therapy have also reported increased patient volumes, but they generally have stronger balance sheets and more stable cash flows.
• ATI's reliance on debt financing and its high leverage ratio are significantly higher than industry averages.
• The company's negative operating cash flow and going concern warning are not typical for established players in the physical therapy sector.

Legal Proceedings

• The company has settled all four class action and derivative lawsuits for $26.5 million, to be paid entirely by insurance.
• The company has recorded an estimated liability of $21.5 million related to the settlements and a corresponding insurance recovery receivable of $21.5 million.
• The company is cooperating with the SEC's review and investigation of certain matters.

Related Party Transactions

• The company's debt includes $17.0 million due to related parties as part of the Senior Secured Term Loan.
• The company's 2L Notes are primarily held by related parties, including Knighthead, Marathon, and Onex.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and going concern warning.
• Employees may be concerned about job security due to the company's financial challenges.
• Customers may be impacted by potential changes in service quality or availability.
• Creditors face increased risk of non-payment due to the company's liquidity issues.

Next Steps

• The company plans to continue its efforts to improve its operating results and cash flow.
• The company is exploring options to raise additional capital.
• The company is working to increase clinical staffing levels and improve clinician productivity.
• The company is focused on increasing patient visit volumes and referrals.

Key Dates

Keywords

physical therapy, outpatient rehabilitation, net patient revenue, patient visits, liquidity, going concern, debt, 2L Notes, clinical staffing, reimbursement rates